Equities

Maitreya Medicare Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MAITREYA:NSI

Maitreya Medicare Ltd

Actions
  • Price (INR)201.35
  • Today's Change-4.60 / -2.23%
  • Shares traded1.20k
  • 1 Year change-29.94%
  • Beta--
Data delayed at least 15 minutes, as of Feb 17 2026 09:58 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Maitreya Medicare Limited is an India-based company, which operates approximately 125 bedded, multispecialty hospitals. It provides multidisciplinary integrated healthcare services, with a focus on primary, secondary and tertiary care. It offers a comprehensive range of healthcare services and super specialties, including cardiology, urology, oncology, laparoscopic surgery, neurology, neurosurgery, spine surgery, nephrology, including dialysis, gastroenterology, gastrointestinal surgery, cardiothoracic surgery, oncosurgery, orthopedic surgery, including joint replacements and arthroscopic surgeries, gynecology and high-risk obstetrics, hepatocellular billary surgery, and critical care medicine, among others. The Company's facility consists of a Cath lab with Ivus/FFR/Rota and an approximately 20-bed Intensive Care Unit (ICU) fully equipped with ECMO/CRRT ventilators and monitors. Its subsidiaries include Maitreya Hospital Private Limited and Maitreya Lifescience Private Limited.

  • Revenue in INR (TTM)459.98m
  • Net income in INR832.35k
  • Incorporated2019
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Invicta Diagnostic Ltd-100.00bn-100.00bn829.75m--------------------------------------------------------------
Maitreya Medicare Ltd459.98m832.35k1.40bn--1,676.714.4484.323.030.12280.122867.8846.430.956314.003.26--0.1732--0.2321--79.87--0.1812--1.921.500.1174---2.31---36.95------
Nephro Care India Ltd676.68m33.97m1.46bn334.0039.992.6319.412.162.212.2144.3133.621.0111.2625.362,025,991.005.07--6.22--72.88--5.02--2.2417.170.00--69.04---17.51------
Data as of Feb 17 2026. Currency figures normalised to Maitreya Medicare Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.